Product Information

ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.6798 per EA under NDC 50742024690. Its NADAC has been published 217 times since Sep 21, 2022.

FDA first approved this application on Apr 6, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET

Isosorbide dinitrate and hydralazine hydrochloride
$0.6798per EA

Strength

37.5; 20 mg/1; mg/1

NDC

50742024690

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215586

FDA Approved

4/6/2022

TE Code

AB

On Market Since

4/12/2022

Pharmacological Classes

Arteriolar Vasodilation
Arteriolar Vasodilator
Nitrate Vasodilator
Nitrates
Vasodilation

Price Statistics

The NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has been published 217 times since Sep 21, 2022, and over the history we have for it it has declined 50.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6798 per EA
All-time high$2.2084 (Aug 16, 2023)
All-time low$0.6798 (Oct 21, 2026)
52-week high$0.7961
52-week low$0.6798
Median price$0.9751
Average price$1.1506
Largest weekly change-22.9% (Aug 23, 2023)
Weeks tracked217
Tracking sinceSep 21, 2022

Price History

1W

0.0%

1M

-4.8%

3M

-5.2%

6M

-9.3%

1Y

-5.8%

3Y

-56.5%

5Y

N/A

All

-50.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.6798 per EA (NDC 50742024690), effective Nov 11, 2026.

How has the price of ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has declined 50.6%. It has been tracked across 217 weekly CMS publications since Sep 21, 2022.

What are the highest and lowest recorded NADAC prices for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?

Since Sep 21, 2022, the NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has ranged from a low of $0.6798 (Oct 21, 2026) to a high of $2.2084 (Aug 16, 2023), with a median of $0.9751 per EA.

Are there cheaper alternatives to ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?

ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET (NDC 50742024690) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.